In metastatic bladder cancer cells, PFN1 facilitates integrin-mediated activation of the Wnt/Ca2+ pathway via PIP2, promoting fibronectin adhesion, actin remodeling, and cell motility. Here, PFN1 is linked to urinary bladder carcinoma.